{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:07:07Z","timestamp":1791094027276,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.cgh.2007.04.021","type":"journal-article","created":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T07:45:21Z","timestamp":1184312721000},"page":"1100-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":227,"title":["A Phase I\/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting Bead"],"prefix":"10.1016","volume":"5","author":[{"given":"Ronnie T.P.","family":"Poon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Kuen","family":"Tso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta W.C.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K.C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Shing","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheung Tat","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2007.04.021_bib1","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1200\/JCO.2002.02.013","article-title":"Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study","volume":"20","author":"Lee","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cgh.2007.04.021_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/bjs.4045","article-title":"Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma","volume":"90","author":"O\u2019Suilleabhain","year":"2003","journal-title":"Br J Surg"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2007.04.021_bib3","first-page":"S124","article-title":"Hepatocellular carcinoma: current management and future trends","volume":"127","author":"Carr","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2007.04.021_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00001622-199901000-00009","article-title":"Embolization and chemoembolization therapy for neuroendocrine tumors","volume":"11","author":"Venook","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.cgh.2007.04.021_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J","article-title":"Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature","volume":"82","author":"Tellez","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cgh.2007.04.021_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.RVI.0000116190.44877.04","article-title":"Chemoembolization of liver metastasis from breast carcinoma","volume":"15","author":"Giroux","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.surg.2005.09.020","article-title":"Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma","volume":"138","author":"Lorenz","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.cgh.2007.04.021_bib9","first-page":"409","article-title":"Distribution of arterial blood flow in human hepatic cancer during chemotherapy\u2013examination by short-lived 81mKr","volume":"97","author":"Sasaki","year":"1985","journal-title":"Surgery"},{"key":"10.1016\/j.cgh.2007.04.021_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/1097-0142(19930101)71:1<50::AID-CNCR2820710109>3.0.CO;2-T","article-title":"Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling","volume":"71","author":"Taniguchi","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/bjc.1996.156","article-title":"Human liver cancer cells and endothelial cells incorporate iodised oil","volume":"73","author":"Bhattacharya","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/bjs.1800811105","article-title":"Iodized oil in the treatment of hepatocellular carcinoma","volume":"81","author":"Bhattacharya","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2007.04.021_bib13","first-page":"97","article-title":"Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer","volume":"114","author":"Kameyama","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.cgh.2007.04.021_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00270-002-2524-6","article-title":"Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency","volume":"26","author":"Geschwind","year":"2003","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2007.04.021_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2007.04.021_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2007.04.021_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/028418501127347278","article-title":"Palliative treatment of hepatocellular carcinoma by chemoembolization","volume":"42","author":"Poyanli","year":"2001","journal-title":"Acta Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1440-1746.2002.02664.x","article-title":"Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization","volume":"17","author":"Lee","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2007.04.021_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(91)90873-A","article-title":"Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: effect of co-administration of Lipiodol","volume":"13","author":"Johnson","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2007.04.021_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","article-title":"DC beads: in-vitro characterization of a drug delivery device for transarterial chemoembolization","volume":"17","author":"Lewis","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib22","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","article-title":"New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer","volume":"12","author":"Hong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cgh.2007.04.021_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","article-title":"Updated treatment approach to hepatocellular carcinoma","volume":"40","author":"Llovet","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cgh.2007.04.021_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0009-9260(97)80303-0","article-title":"Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance","volume":"52","author":"Ngan","year":"1997","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2007.04.021_bib26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":"A clinicopathologic analysis of Adriamycin cardiotoxicity","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00944177","article-title":"Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria","volume":"10","author":"Green","year":"1992","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.cgh.2007.04.021_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00270-004-0153-y","article-title":"Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate","volume":"28","author":"Rand","year":"2005","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1051-0443(96)72881-6","article-title":"Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow-up","volume":"7","author":"Ngan","year":"1996","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.cgh.2007.04.021_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cgh.2007.04.021_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.5414\/CPP41598","article-title":"The influence of liver metastases on the pharmacokinetics of doxorubicin\u2014a population-based pharmacokinetics project of the CESAR-APOH","volume":"41","author":"Muller","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2007.04.021_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00685565","article-title":"Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity","volume":"34","author":"Dobbs","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cgh.2007.04.021_bib33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(20010501)91:9<1826::AID-CNCR1203>3.0.CO;2-J","article-title":"Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors","volume":"91","author":"Hong","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib34","first-page":"1079","article-title":"How large should a phase II trial of a new drug be?","volume":"71","author":"Simon","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.cgh.2007.04.021_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2007.04.021_bib36","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(19920801)70:3<585::AID-CNCR2820700308>3.0.CO;2-#","article-title":"Chemoembolisation of hepatocellular carcinomas: a study of the biodistribution and pharmacokinetics of doxorubicin","volume":"70","author":"Raoul","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.1840100119","article-title":"A 5-year experience of Lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma","volume":"10","author":"Kanematsu","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2007.04.021_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00686011","article-title":"Treatment of inoperable hepatocellular carcinoma by intra-arterial Lipiodol and 4-epidoxorubicin","volume":"29","author":"Leung","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cgh.2007.04.021_bib40","first-page":"223","article-title":"Selective regional chemotherapy of unresectable hepatic tumors using Lipiodol","volume":"14","author":"Novell","year":"1991","journal-title":"HBP Surg"},{"key":"10.1016\/j.cgh.2007.04.021_bib41","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/1097-0142(19950515)75:10<2427::AID-CNCR2820751007>3.0.CO;2-J","article-title":"Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma","volume":"75","author":"Stefanini","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2007.04.021_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.COC.0000018174.53573.67","article-title":"Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma","volume":"26","author":"Furuse","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.cgh.2007.04.021_bib43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejso.2005.11.003","article-title":"Chemoocclusion vs chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial","volume":"32","author":"Kirchhoff","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.cgh.2007.04.021_bib44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2168.1998.00664.x","article-title":"Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization","volume":"85","author":"Liu","year":"1998","journal-title":"Br J Surg"},{"key":"10.1016\/j.cgh.2007.04.021_bib45","first-page":"1156","article-title":"Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma","volume":"26","author":"Raoul","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2007.04.021_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9610(92)90039-T","article-title":"Primary treatment of hepatocellular carcinoma by arterial chemoembolization","volume":"163","author":"Bismuth","year":"1992","journal-title":"Am J Surg"},{"key":"10.1016\/j.cgh.2007.04.021_bib47","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2007.04.021_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial","volume":"29","author":"Pelletier","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2007.04.021_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.0.CO;2-J","article-title":"Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence","volume":"73","author":"Poon","year":"2000","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.cgh.2007.04.021_bib50","first-page":"2551","article-title":"Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage","volume":"25","author":"Hwang","year":"2005","journal-title":"Anticancer Res"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507004624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356507004624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:01:00Z","timestamp":1761541260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356507004624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1542356507004624"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2007.04.021","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase I\/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting Bead","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2007.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}